Výborná léčebná odpověď na pembrolizumab u 51letého nemocného s metastatickým uroteliálním karcinomem

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	Excellent therapeutic response to pembrolizumab in a 51-year-old patient with metastatic urothelial carcinoma
Authors	BOŠANSKÁ Barbora VARGA Gabriel EID Michal SAID Dávid FEDORKO Michal
Year of publication	2025
Type	Article in Periodical
Magazine / Source	Česká urologie
MU Faculty or unit	Faculty of Medicine
Citation
web	https://czechurol.cz/artkey/cur-202501-0007_vyborna_lecebna_odpoved_na_pembrolizumab_u_51leteho_nemocneho_s_metastatickym_urotelialnim_karcinomem.php
Doi	https://doi.org/10.48095/cccu2025008
Keywords	imunotherapy; pembrolizumab; next-generation sequencing; urothelial carcinoma
Description	The authors present a case report of a patient suffered from metastatic urothelial carcinoma and discuss the role and efficacy of pembrolizumab in the context of comprehensive genomic profiling of tumor tissue.
Related projects:	Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit XII